Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,159) with videos related to
Page
of 116
Sort By:
Nature Communications
|
July 30, 2024
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis
Majid Pahlevan Kakhki, Antonino Giordano, Chiara Starvaggi Cucuzza, et al.
Journal of Neurology
|
January 17, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Journal of Neurology
|
May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility
Melissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
The Lancet. Neurology
|
June 17, 2021
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P Wattjes, Olga Ciccarelli, Daniel S Reich, et al.
Neuroimage. Clinical
|
January 5, 2021
Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
Jessica Burggraaff, Yao Liu, Juan C Prieto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Gaia Chiara Santi, Eleonora Catricalà, Stephanie Kwan, et al.
Annals of Neurology
|
February 12, 2022
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis
Ermelinda De Meo, Massimo Filippi, Maria Trojano, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy
|
March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Page
of 116
Search research articles
Search
Showing results (1071-1080 of 1,159) with videos related to
Sort By:
Page
of 116
Nature Communications
|
July 30, 2024
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis
Majid Pahlevan Kakhki, Antonino Giordano, Chiara Starvaggi Cucuzza, et al.
Journal of Neurology
|
January 17, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Journal of Neurology
|
May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility
Melissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
The Lancet. Neurology
|
June 17, 2021
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P Wattjes, Olga Ciccarelli, Daniel S Reich, et al.
Neuroimage. Clinical
|
January 5, 2021
Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
Jessica Burggraaff, Yao Liu, Juan C Prieto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Gaia Chiara Santi, Eleonora Catricalà, Stephanie Kwan, et al.
Annals of Neurology
|
February 12, 2022
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis
Ermelinda De Meo, Massimo Filippi, Maria Trojano, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy
|
March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Page
of 116